Genome Biologics Company

Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.
Technology: Biotechnology, Genetics, Pharmaceutical, Therapeutics
Industry: Early Drug Development
Headquarters: Hessen, Sachsen-Anhalt, Germany
Founded Date: 2017-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: 2866097
Last Funding Date: 2018-09-01
Last Funding Type: Grant

Visit Website
Register and Claim Ownership